Recently, experimental data suggested protective effects of CXCR4 and CXCR7 antagonism during pulmonary inflammation and provided evidence for a link between the SDF-1-CXCR4/CXCR7 axis and adenosine receptor signaling [6,32]. The gene discussed is ACKR3; the disease is inflammation.